Page last updated: 2024-10-30

lorazepam and Anti-N-Methyl-D-Aspartate Receptor Encephalitis

lorazepam has been researched along with Anti-N-Methyl-D-Aspartate Receptor Encephalitis in 2 studies

Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.

Anti-N-Methyl-D-Aspartate Receptor Encephalitis: Disorder characterized by symptoms of CATATONIA; HYPOVENTILATION; DYSKINESIAS; ENCEPHALITIS; and SEIZURES followed by a reduced CONSCIOUSNESS. It is often followed by a viral-like prodrome. Many cases are self-limiting and respond well to IMMUNOMODULATORY THERAPIES against the NMDA RECEPTORS antibodies.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yuan, N1
Glezer, A1
Jørgensen, A1
Hansen, BS1
Stanislaus, S1
Düring, S1
Jørgensen, MB1
Pinborg, LH1
Kondziella, D1

Other Studies

2 other studies available for lorazepam and Anti-N-Methyl-D-Aspartate Receptor Encephalitis

ArticleYear
A young woman presenting with psychotic and mood symptoms from anti-N-methyl-D-aspartate receptor (NMDA-R) encephalitis: an emerging diagnosis.
    International journal of psychiatry in medicine, 2013, Volume: 46, Issue:4

    Topics: Adult; Affective Disorders, Psychotic; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Antibodies,

2013
Anti-N-methyl-D-aspartate receptor encephalitis is an important differential diagnosis in acute psychiatric disease.
    Acta psychiatrica Scandinavica, 2015, Volume: 131, Issue:1

    Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Anti-Anxiety Agents; Anti-N-Methyl-D-Aspa

2015